Valuing SF-6Dv2 in Australia Using an International Protocol

Brendan Mulhern1, Richard Norman2, John Brazier3

  • 1Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia. Brendan.mulhern@chere.uts.edu.au.

Pharmacoeconomics
|July 12, 2021
PubMed
Summary

This study developed an Australian SF-6Dv2 value set using international methods. The new value set improves health technology assessment decisions in Australia.